
Eyecelerator @ Park City 2025
Save the Date: Eyecelerator @ AAO 2025 | Oct. 16 | Orlando, FL
CONFERENCE SPEAKERS

Osanni Bio, Inc.
Michael Ackermann, PhD
CEO

Lacristat.AI​
Dimitri Azar, MD, MBA
​President and CEO

Tenpoint Therapeutics, Ltd.
Ben Bergo, MA
President & Chief Business Officer

Ciociola Regulatory Consultancy, LLC
Art Ciociola, PhD
Principal Member​

AbbVie Inc.
Randy Craven, MD
Senior Medical Director, Eyecare, Research and Development

Collaborative Community on Ophthalmic Innovation (CCOI)
Malvina Eydelman, MD
CEO

Leerink Partners, LLC
Andrew Gitkin
Senior Managing Director, Healthcare Investment Banking

Wills Eye Hospital
Allen C. Ho, MD
Director of Retina Research

University of Southern California
Mark Humayun, MD, PhD
Professor of Ophthalmology

Sydnexis
​
Patrick Johnson, PhD
President
​

Moorfields Eye Hospital & University College London
Anthony Khawaja, PhD, MA
Professor

InterWest Partners​
Gil Kliman, MD
Managing Partner

Center for Visual Science, University of Rochester | EyesVision
Susana Marcos, PhD
Director | Co-Founder​
​

American Academy of Ophthalmology
Stephen D. McLeod, MD
CEO​

Re-Vana Therapeutics
Michael J. O'Rourke
CEO

California Retina Associates
Dante J. Pieramici, MD
Medical Director of Clinical Research

See Clearly Vision Group
Rajesh K. Rajpal, MD
Founder

California Baptist University | Blink Frames
Matthew Rickard, PhD
​Professor of Biomedical Engineering | Co-Founder

RA Capital Management, L.P.
Zach Scheiner, PhD
Principal
.jpg)
University of Iowa
Christine W. Sindt, OD
Professor, Clinical Ophthalmology

Neurotech Pharmaceuticals, Inc.
Rich Small
CEO

Vance Thompson Vision
Vance M. Thompson, MD
Founder​​

Duke University
Lejla Vajzovic, MD
Associate Professor of Ophthalmology

Visionary Ventures
Jeff Weinhuff, MBA
Managing Partner
​

California Retina Consultants
Robert L. Avery, MD
Founder/CEO

Nanoscope Therapeutics, Inc.
Samuel Barone, MD
Chief Medical Officer

Osheru
Patricia Buehler, MD, MPH
Co-Founder and CEO

Lineage Cell Therapeutics
Brian Culley, MS, MBA
CEO

4DMT
Dhaval Desai, PharmD
Chief Development Officer
​

Revelation Partners
​
Doug Fisher, MD, MBA
Partner

Topcon Healthcare​
Rupe Hansra, OD
Vice President, Professional Affairs
​

STAAR Surgical
Keith Holliday, PhD
Former Chief Technology Officer

Market Scope
Kristen Harmon Ingenito, MBA
CEO

Center for Devices & Radiological Health (CDRH), FDA
Doug Kelly, MD, MBA
Former Deputy Center Director for Science, Chief Scientist

Alcon
​
Terry Kim, MD
​Chief Medical Officer

University of California San Francisco
Jonathan Li, MD
Assistant Professor

Glaukos​
​
Cody McKenzie
VP, Global Marketing Strategy & Franchise Management

Medevise Consulting SAS
Kristine Morrill
Founder & President

REGENXBIO, Inc.
Ram Palanki, PharmD
Executive Vice President & Chief Commercial Officer

EssilorLuxottica
Olga Prenat, MSc
Global Head of Medical Affairs

EyePoint Pharmaceuticals, Inc.
Ramiro Ribeiro, MD, PhD
Chief Medical Officer

Ocular Therapeutix, Inc.
Namrata Saroj, OD
Chief Business Officer

Alcon
Rob Scott, PhD, MS
VP, Intraocular Devices R&D

Stanford Medicine
Kuldev Singh, MD, MPH
Professor of Ophthalmology

Adverum Biotechnologies, Inc.
Peter Soparkar
COO

Singapore National Eye Centre
Daniel Ting, PhD, M Med
Senior Consultant

Ocular Therapeutix, Inc.
Nadia K. Waheed, MD, MPH
Chief Medical Officer

University of Utah | Qlaris Bio, Inc.
Barbara Wirostko, MD
​Adjunct Professor, Ophthalmology & Biomedical Engineering | Co-Founder